Arkolith/Insider Trading/OPNT/Form 4

Ruth Matthew R.

Chief Commercial OfficerOPIANT PHARMACEUTICALS, INC. (OPNT) · full profile →Form 4 · filed Jul 21, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$12K
Net Open-Market Flow
-$12K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 20, 2022Sell(S)1K$10.62$12K30K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001385508-22-000114) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML